Immunocore
IMCR
IMCR
115 hedge funds and large institutions have $1.4B invested in Immunocore in 2025 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 42 increasing their positions, 33 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
7% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 14
5% more capital invested
Capital invested by funds: $1.34B → $1.4B (+$63.4M)
1% more funds holding
Funds holding: 114 → 115 (+1)
Holders
115
Holding in Top 10
3
Calls
$6.54M
Puts
$3.48M
Top Buyers
| 1 | +$26.5M | |
| 2 | +$24M | |
| 3 | +$13.9M | |
| 4 |
TCM
Tang Capital Management
San Diego,
California
|
+$10.7M |
| 5 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
+$10.4M |
Top Sellers
| 1 | -$14.4M | |
| 2 | -$8.89M | |
| 3 | -$8.55M | |
| 4 |
AC
Armistice Capital
New York
|
-$6.59M |
| 5 |
BNP Paribas Financial Markets
Paris,
France
|
-$4.53M |